 |
Translate Bio
Last updated: September 15, 2024
Ronald C. Renaud, CEO
USA | Funding: $442.6M (+)
Website: https://translatebio.wpengine.com/
Translate Bio is a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
Website: https://translatebio.wpengine.com/
Translate Bio is a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
